Literature DB >> 10364437

Lithium chloride induces the expression of tyrosine hydroxylase in hNT neurons.

T Zigova1, A E Willing, E M Tedesco, C V Borlongan, S Saporta, G L Snable, P R Sanberg.   

Abstract

In the present study, several doses of lithium chloride were tested for their ability to induce the expression of tyrosine hydroxylase (TH) in neurons derived from a human teratocarcinoma cell line (hNT) after 5 and 10 days in vitro (DIV). Following immunocytochemical staining for tyrosine hydroxylase, the percentage of TH-positive neurons was determined and morphometric analysis, including mean soma profile area and neuritic length, was performed. hNT neurons responded to lithium treatment in a dose-dependent manner. In 5 DIV, the most effective dose of lithium chloride (1.0 mM) increased the number of TH-positive neurons approximately sixfold. In addition, both TH-positive hNT neuron mean soma profile area and neurite length were significantly larger than controls by 60 and 70%, respectively. Moreover, even after withdrawal of lithium chloride on day 5, the number of TH-positive neurons in 10 DIV cultures remained significantly increased. These data suggest that hNT cells are indeed responsive to lithium exposure and may serve as a continual source of TH-expressing neurons in new therapeutic approaches to degenerative brain disease. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364437     DOI: 10.1006/exnr.1999.7054

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

Review 1.  Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.

Authors:  Yossef S Levy; Merav Stroomza; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 2.  Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.

Authors:  Connor Stonesifer; Sydney Corey; Shaila Ghanekar; Zachary Diamandis; Sandra A Acosta; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2017-07-23       Impact factor: 11.685

3.  Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo.

Authors:  Ming Yang; Angela E Donaldson; Cheryl E Marshall; James Shen; Lorraine Iacovitti
Journal:  Cell Transplant       Date:  2004       Impact factor: 4.064

4.  Lithium-induced neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by GSK3β inhibition-independent pathways.

Authors:  Thorsten R Doeppner; Britta Kaltwasser; Eduardo H Sanchez-Mendoza; Ahmet B Caglayan; Mathias Bähr; Dirk M Hermann
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

5.  Lithium Improves Dopamine Neurotransmission and Increases Dopaminergic Protein Abundance in the Striatum after Traumatic Brain Injury.

Authors:  Shaun W Carlson; C Edward Dixon
Journal:  J Neurotrauma       Date:  2018-08-13       Impact factor: 5.269

6.  Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury.

Authors:  Brooke Bonsack; Sydney Corey; Alex Shear; Matt Heyck; Blaise Cozene; Nadia Sadanandan; Henry Zhang; Bella Gonzales-Portillo; Michael Sheyner; Cesar V Borlongan
Journal:  CNS Neurosci Ther       Date:  2020-05-01       Impact factor: 5.243

7.  Mesenchymal Stem Cell-Induced Anti-Neuroinflammation Against Traumatic Brain Injury.

Authors:  Blaise Cozene; Nadia Sadanandan; Jeffrey Farooq; Chase Kingsbury; You Jeong Park; Zhen-Jie Wang; Alexa Moscatello; Madeline Saft; Justin Cho; Bella Gonzales-Portillo; Cesar V Borlongan
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

8.  Lithium's gene expression profile, relevance to neuroprotection A cDNA microarray study.

Authors:  Raymond Farah; Rola Khamisy-Farah; Tamar Amit; Moussa B H Youdim; Zaher Arraf
Journal:  Cell Mol Neurobiol       Date:  2013-01-17       Impact factor: 4.231

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.